Experimental Alzheimer's Drug Shows Promise in Delaying Symptoms
Scientists report that long-term use of gantenerumab might prevent cognitive decline in people with genetic predisposition to early-onset Alzheimer's.
Original source
Read on DecryptRelated market context
Coinbase Quantum Report Warns Millions Of Bitcoin Could Face Future Security Risks
TL;DR Coinbase’s Quantum Advisory Council published a report on post-quantum migration and abandoned coins. The report estimates t...
Bitfinex Report Highlights Tokenization as the Key to Venezuela’s Economic Rebuild
In a recent report, Bitfinex Securities highlights the relevance of tokenization in modernizing and streamlining Venezuelan market...
Humanity Protocol’s $36M hack linked to suspected North Korean hackers, Quantstamp reports
The incident underscores the urgent need for improved cybersecurity measures and key management practices to protect against sophi...
$1.5 Trillion Transacted: Rain Report Reveals the Massive Scale of Latam’s Stablecoin Economy
The crypto card company stressed that these volumes result from a more conscious use of stablecoins, driven by concrete problem-so...
MetaMask reports connectivity disruption across multiple blockchain networks
The disruption highlights the vulnerability of decentralized finance ecosystems to single points of failure, impacting user trust...
Coinbase report flags Bitcoin cold wallets exposed to quantum risks
The potential quantum threat to Bitcoin highlights the urgent need for governance solutions to protect vulnerable assets and ensur...